Breast Care

Papers
(The TQCC of Breast Care is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
St. Gallen/Vienna 2021: A Brief Summary of the Consensus Discussion on Customizing Therapies for Women with Early Breast Cancer85
AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 202147
AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 202242
A Novel First-Line Treatment Alternative for Noncomplicated Idiopathic Granulomatous Mastitis: Combined İntralesional Steroid İnjection with Topical Steroid Administration19
AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 202118
Nonsurgical Prevention Strategies in <b><i>BRCA1</i></b> and <b><i>BRCA2</i></b> Mutation Carriers18
Desmoid Type Fibromatosis of the Breast: Ten-Year Institutional Results of Imaging, Histopathology, and Surgery14
The Role of the Hippo Pathway in Breast Cancer Carcinogenesis, Prognosis, and Treatment: A Systematic Review13
Diffusion-Weighted Imaging of Different Breast Cancer Molecular Subtypes: A Systematic Review and Meta-Analysis13
Breast Disorders in Adolescence: A Review of the Literature13
Consensus Recommendations of the German Consortium for Hereditary Breast and Ovarian Cancer12
Prognostic Roles of Neutrophil-to-Lymphocyte Ratio and Stromal Tumor-Infiltrating Lymphocytes and Their Relationship in Locally Advanced Triple-Negative Breast Cancer Treated with Neoadjuvant Chemothe12
HER2-Low Breast Cancer: Where Are We?12
False Negativity of Targeted Axillary Dissection in Breast Cancer11
Treatment of Luminal Metastatic Breast Cancer beyond CDK4/6 Inhibition: Is There a Standard of Care in Clinical Practice?10
Oncoplastic Surgery in Breast-Conserving Treatment: Patient Profile and Impact on Quality of Life10
AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 202210
Resistance Exercise for Breast Cancer Patients? Evidence from the Last Decade9
Risk Factors for Idiopathic Granulomatous Mastitis Recurrence after Patient-Tailored Treatment: Do We Need an Escalating Treatment Algorithm?9
Magnetic Seed (Magseed) Localisation in Breast Cancer Surgery: A Multicentre Clinical Trial9
Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 20239
Impact of Oncoplastic Breast Surgery on Rate of Complications, Time to Adjuvant Treatment, and Risk of Recurrence9
Radiotherapy-Induced Fatigue in Breast Cancer Patients9
Malignancy Rate and Malignancy Risk Assessment in Different Lesions of Uncertain Malignant Potential in the Breast (B3 Lesions): An Analysis of 192 Cases from a Single Institution8
Identifying High-Risk Triple-Negative Breast Cancer Patients by Molecular Subtyping8
St. Gallen/Vienna 2023: Optimization of Treatment for Patients with Primary Breast Cancer – A Brief Summary of the Consensus Discussion8
Association between Shoulder Range of Motion and Pain Catastrophizing Scale in Breast Cancer Patients after Surgery7
Sexual Dysfunction in Postmenopausal Women with Breast Cancer on Adjuvant Aromatase Inhibitor Therapy7
Factors Indicating Surgical Excision in Classical Type of Lobular Neoplasia of the Breast7
Low-Dose Methotrexate Use in Idiopathic Granulomatous Mastitis: An Alternative Treatment Method7
Risk-Adjusted Cancer Screening and Prevention (RiskAP): Complementing Screening for Early Disease Detection by a Learning Screening Based on Risk Factors6
ABC6 Consensus: Assessment by a Group of German Experts6
CDK4/6 Inhibitors in Advanced HR+/HER2 – Breast Cancer: A Multicenter Real-World Data Analysis6
From <b><i>BRCA1</i></b> to Polygenic Risk Scores: Mutation-Associated Risks in Breast Cancer-Related Genes6
Current Understanding and Management of Plasma Cell Mastitis: Can We Benefit from What We Know?6
Targeted Axillary Dissection after Chemotherapy: Feasibility Study with Clip and Carbon Dye Tattoo – Neotarget Trial5
Patient Preferences: Results of a German Adaptive Choice-Based Conjoint Analysis (Market Research Study Sponsored by Eli Lilly and Company) in Patients on Palliative Treatment for Advanced Breast Canc5
Long-Term Results of the TARGIT-A Trial: More Questions than Answers5
Immunotherapy in HER2-Positive Breast Cancer: A Systematic Review5
Ribociclib-Induced Pneumonitis: A Case Report5
Quality of Life Effects of an Oral Fixed Combination of Netupitant and Palonosetron in Chemotherapy-Induced Nausea and Vomiting Prevention: Real-World Evidence in Patients with Breast Cancer Receiving5
Impact of Breast Cancer Diagnosis and Treatment on Work-Related Life and Financial Factors5
AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 20235
Multistage Latissimus Dorsi Flap with Implant for Complex Post-Mastectomy Reconstruction: An Old but Still Current Technique5
Management of Chemotherapy-Induced Nausea and Vomiting with Trastuzumab Deruxtecan: A Case Series5
Double Heterozygous Mutations in the <b><i>BRCA2</i></b> and <b><i>ATM</i></b> Genes: A Case Report and Review of the Literature5
Adherence to Newly Implemented Tamoxifen Therapy for Breast Cancer Patients in Rural Western Ethiopia5
Implant Replacement or Removal: What Happens after Capsular Contracture? A German Study Examining Breast Implant Revision Surgery and Patient Choices in 946 Cases5
The Identification of Gene Expression Profiles Associated with Granulomatous Mastitis4
Augmented Reality in Breast Surgery Education4
Patient-Reported Outcomes in Free-Flap Breast Reconstructive Surgery over Time (PRO-BREST)4
Mammary Chain Irradiation in Left-Sided Breast Cancer: Can We Reduce the Risk of Secondary Cancer and Ischaemic Heart Disease with Modern Intensity-Modulated Radiotherapy Techniques?4
Effectiveness of Peer Support on Quality of Life and Anxiety in Breast Cancer Patients: A Systematic Review and Meta-Analysis4
Sentinel Lymph Node Biopsy May Prevent Unnecessary Axillary Dissection in Patients with Inflammatory Breast Cancer Who Respond to Systemic Treatment4
De-Escalating Axillary Surgery in Node-Positive Breast Cancer Treated with Neoadjuvant Systemic Therapy4
Phenotype Discordance between Primary Tumor and Metastasis Impacts Metastasis Site and Outcome: Results of WSG-DETECT-PriMet4
Treatments for Periductal Mastitis: Systematic Review and Meta-Analysis4
Objective Response to First-Line Treatment as a Predictor of Overall Survival in Metastatic Breast Cancer: A Retrospective Analysis from Two Centers over a 25-Year Period4
Ten-Year Survival of Breast Cancer in Iran: A National Study (Retrospective Cohort Study)4
Second-Degree Type 2 Atrioventricular Block Requiring Permanent Cardiac Pacing in Patients on CDK4/6 Inhibitors: Report of Two Cases4
Quality and Quantity: How to Organize a Countrywide Genetic Counseling and Testing4
Docetaxel-Induced Peripheral Neuropathy in Breast Cancer Patients Treated with Adjuvant or Neo-Adjuvant Chemotherapy4
Quality Analysis of YouTube Videos Presenting Shoulder Exercises after Breast Cancer Surgery4
Survey on Physicians’ Knowledge and Training Needs in Genetic Counseling in Germany3
The Role of Social Media and Breast Cancer: How Does It Impact Patients?3
Conditional Disease-Free and Overall Survival of 1,858 Young Women with Non-Metastatic Breast Cancer and with Participation in a Post-Therapeutic Rehab Programme according to Clinical Subtypes3
Awareness and Availability of Routine Germline <b><i>BRCA1/2</i></b> Mutation Testing in Patients with Advanced Breast Cancer in Germany3
First Experiences with Alpelisib in Clinical Routine: Case Reports from a German Breast Center3
Current Standards and Future Outlooks in Metastatic Her2-Positive Breast Cancer3
Long-Term Outcome Analysis and Technical Refinements after Autologous Breast Reconstruction with PAP Flap: What We Have Learnt3
Prognostic Impact of Immunoglobulin Kappa C in Breast Cancer Patients Treated with Adjuvant Chemotherapy3
Treatment Patterns, Safety, and Patient Reported Outcomes among Adult Women with Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer with or without, or with Unknown, BRCA1/2 Muta3
Breast Adjuvant Radiotherapy Amid the COVID-19 Crisis in a Hub Cancer Center, Lombardy, Italy3
Expert Discussion: Highlights from ABC6: Bridging the Gap and Insights in This First Virtual ABC Conference and from 10 Years ABC Consensus3
Post-Neoadjuvant Gemcitabine and Cisplatin with Regional Hyperthermia for Patients with Triple-Negative Breast Cancer and Non-pCR after Neoadjuvant Chemotherapy: A Single-Institute Experience3
Carboplatin-Cyclophosphamide or Paclitaxel without or with Bevacizumab as First-Line Treatment for Metastatic Triple-Negative Breast Cancer (BOOG 2013-01)3
Influence of Breast Reduction Surgery on Long-Term Breast Cancer Risk in Austria3
Innovative Standards in Oncoplastic Breast Conserving Surgery: From Radical Mastectomy to Extreme Oncoplasty3
PITX2 DNA-Methylation: Predictive versus Prognostic Value for Anthracycline-Based Chemotherapy in Triple-Negative Breast Cancer Patients3
Clinical Importance of PGRMC1 in Hormone Responsive Breast Cancer3
0.031258106231689